VRSK Stock Analysis: Verisk Analytics | NASDAQ

Underwriting Analytics, Claims Solutions, Catastrophe Modeling, Fraud Detection

Total Rating 55

Safety 95

Buy Signal 0.03

Consulting Services
Industry Rotation: +20.7

Market Cap: 24.8B
Avg Turnover: 211M

Risk 3d forecast

Volatility37.3%

VaR 5^th Pctl6.01%

VaR vs Median-1.86%

Reward TTM

Sharpe Ratio-0.49

Rel. Str. IBD21.9

Rel. Str. Peer Group21.2 pctl

Character TTM

Beta-0.532

Beta Downside-0.245

Hurst Exponent0.587

Choppyness67.4%

Drawdowns 3y

Max DD50.81%

CAGR/Max DD-0.11

CAGR/Mean DD-0.33

EPS (Earnings per Share)

EPS CAGR: 9.78%
EPS Trend: 98.2%

Last SUE: 0.61
Qual. Beats: 0

Revenue

Rev. CAGR: 9.49%
Rev. Trend: 88.3%

Last SUE: 0.39
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan +0.7% 5

Feb -1.1% 40

Mar -0.4% 7

Apr +0.5% 15

May -1.0% 5

Jun +0.9% 18

Jul +3.1% 29

Aug +2.2% 9

Sep -3.5% 59

Oct -1.7% 12

Nov +2.7% 59

Dec -2.3% 60

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: VRSK Verisk Analytics

Verisk Analytics, Inc. (VRSK) is a data analytics and technology provider serving the global insurance industry, with operations in the United States and internationally. Founded in 1971 and headquartered in Jersey City, New Jersey, the company went public on NASDAQ in October 2009.

Verisks offerings are organized across underwriting and claims workflows. Underwriting solutions include policy language, rating rules, loss costs, catastrophe modeling, life insurance analytics, specialty business management, and international underwriting tools. Claims solutions cover property estimating, anti-fraud detection, casualty claims workflow automation, and international personal injury and motor claims support.

The business operates on a data-driven, subscription- and license-based model typical of insurance-focused analytics vendors, monetizing proprietary datasets and decision-support software for insurers, reinsurers, and regulators. The company is classified within the Industrials sector under Research & Consulting Services, reflecting its role as a specialized information services firm rather than a traditional consultancy.

Headlines to Watch Out For

Insurance subscription revenue growth drives margin expansion
Catastrophe modeling demand rises with climate risk exposure
Acquisitions expand specialty and international insurance analytics

Piotroski VR-10 (Strict) 8.0

Net Income: 885.5m TTM > 0 and > 6% of Revenue
FCF/TA: 0.28 > 0.02 and ΔFCF/TA 6.22 > 1.0
NWC/Revenue: 0.19% < 20% (prev 16.01%; Δ -15.81% < -1%)
CFO/TA 0.33 > 3% & CFO 1.50b > Net Income 885.5m
Net Debt (4.23b) to EBITDA (1.68b): 2.52 < 3
Current Ratio: 1.01 > 1.5 & < 3
Outstanding Shares: last quarter (130.9m) vs 12m ago -6.76% < -2%
Gross Margin: 67.66% > 18% (prev 69.39%; Δ -1.73% > 0.5%)
Asset Turnover: 67.51% > 50% (prev 62.28%; Δ 5.22% > 0%)
Interest Coverage Ratio: 6.94 > 6 (EBIT TTM 1.35b / Interest Expense TTM 195.1m)

Altman Z'' 7.65

A: 0.00 (Total Current Assets 1.12b - Total Current Liabilities 1.12b) / Total Assets 4.50b
B: 1.81 (Retained Earnings 8.14b / Total Assets 4.50b)
C: 0.29 (EBIT TTM 1.35b / Avg Total Assets 4.65b)
D: -0.21 (Book Value of Equity -1.19b / Total Liabilities 5.68b)
Altman-Z'' = 7.65 = AAA

Beneish M -3.21

DSRI: 0.68 (Receivables 456.3m/641.5m, Revenue 3.14b/2.99b)
GMI: 1.03 (GM 69.39% / 67.66%)
AQI: 1.06 (AQ_t 0.59 / AQ_t-1 0.56)
SGI: 1.05 (Revenue 3.14b / 2.99b)
TATA: -0.14 (NI 885.5m - CFO 1.50b) / TA 4.50b)
Beneish M = -3.21 (Cap -4..+1) = AA

What is the price of VRSK shares?

As of October 28, 2026, the stock is trading at USD 187.73 with a total of 1,132,472 shares traded. Over the past week, the price has changed by -1.65%, over one month by +11.90%, over three months by -8.92% and over the past year by -18.86%.

Current recommended Stop Loss: 179.90 (which is 4.2% or 1.2 ATR below the current price).

Is VRSK a buy, sell or hold?

Verisk Analytics has received a consensus analysts rating of 3.95. Therefore, it is recommended to buy VRSK.

StrongBuy: 7
Buy: 4
Hold: 8
Sell: 0
StrongSell: 0

What are the forecasts/targets for the VRSK price?

Analysts Target Price	226.5	20.6%

Verisk Analytics (VRSK) - Fundamental Data Overview as of 21 October 2026

Market Cap USD = 24.8b (24.8b USD * 1.0 USD.USD)
P/E Trailing = 29.0645
P/E Forward = 20.0803
P/S = 7.8529
P/B = 74.895
P/EG = 1.4456
Revenue TTM = 3.14b USD
EBIT TTM = 1.35b USD
EBITDA TTM = 1.68b USD
Long Term Debt = 4.21b USD (from longTermDebt, last quarter)
Short Term Debt = 282.8m USD (from shortTermDebt, last quarter)
Debt = 4.78b USD (from shortLongTermDebtTotal, last quarter) + Leases 161.7m
Net Debt = 4.23b USD (calculated: Debt 4.78b - CCE 551.4m)
Enterprise Value = 29.0b USD (24.8b + Debt 4.78b - CCE 551.4m)
Interest Coverage Ratio = 6.94 (Ebit TTM 1.35b / Interest Expense TTM 195.1m)
EV/FCF = 23.47x (Enterprise Value 29.0b / FCF TTM 1.24b)
FCF Yield = 4.26% (FCF TTM 1.24b / Enterprise Value 29.0b)
FCF Margin = 39.43% (FCF TTM 1.24b / Revenue TTM 3.14b)
Net Margin = 28.24% (Net Income TTM 885.5m / Revenue TTM 3.14b)
Gross Margin = 67.66% ((Revenue TTM 3.14b - Cost of Revenue TTM 1.01b) / Revenue TTM)
Gross Margin QoQ = 71.05% (prev 69.77%)
Tobins Q-Ratio = 6.45 (Enterprise Value 29.0b / Total Assets 4.50b)
Interest Expense / Debt = 4.08% (Interest Expense 195.1m / Debt 4.78b)
Taxrate = 10.68% (123.8m / 1.16b)
NOPAT = 1.21b (EBIT 1.35b * (1 - 10.68%))
Current Ratio = 1.01 (Total Current Assets 1.12b / Total Current Liabilities 1.12b)
Debt / Equity = -4.02 (negative equity) (Debt 4.78b / totalStockholderEquity, last quarter -1.19b)
Debt / EBITDA = 2.52 (Net Debt 4.23b / EBITDA 1.68b)
Debt / FCF = 3.42 (Net Debt 4.23b / FCF TTM 1.24b)
Total Stockholder Equity = -417.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.06% (Net Income 885.5m / Total Assets 4.50b)
RoE = -212.0% (negative equity) (Net Income TTM 885.5m / Total Stockholder Equity -417.8m)
RoCE = 35.74% (EBIT 1.35b / Capital Employed (Equity -417.8m + L.T.Debt 4.21b))
RoIC = 34.50% (NOPAT 1.21b / Invested Capital 3.51b)
WACC = 3.83% (E(24.8b)/V(29.6b) * Re(3.87%) + D(4.78b)/V(29.6b) * Rd(4.08%) * (1-Tc(0.11)))
Discount Rate = 3.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.66 | Cagr: -4.16%
[DCF] Terminal Value 77.97% ; FCFF base≈1.15b ; Y1≈1.32b ; Y5≈1.94b
[DCF] Fair Price = 190.6 (EV 29.2b - Net Debt 4.23b = Equity 25.0b / Shares 131.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.18 | EPS CAGR: 9.78% | SUE: 0.61 | # QB: 0
Revenue Correlation: 88.28 | Revenue CAGR: 9.49% | SUE: 0.39 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.92 | Chg30d=-0.27% | Revisions=-50% | Analysts=15
EPS current Year (2026-12-31): EPS=7.70 | Chg30d=-0.06% | Revisions=-50% | GrowthEPS=+7.6% | GrowthRev=+4.8%
EPS next Year (2027-12-31): EPS=8.71 | Chg30d=+0.08% | Revisions=+50% | GrowthEPS=+13.0% | GrowthRev=+6.8%
[Analyst] Revisions Ratio: -25% (up=3, down=6)